Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Early stage pharmaceutical company Alitair Pharmaceuticals will offer benzonatate formulation with Rx-to-OTC switch potential.
Subscribe to our email newsletter
Alitair provided additional details regarding its ‘398 patent specific to formulations of benzonatate.
At present, benzonatate is the only non-narcotic prescription cough product available, according to the company
The tablet eliminates the potential for numbing, thus reducing or eliminating the danger of choking.